Characterization of the Specificity, Functionality, and Durability of Host T‐Cell Responses Against the Full‐Length Hepatitis E Virus
Open Access
- 15 September 2016
- journal article
- research article
- Published by Wolters Kluwer Health in Hepatology
- Vol. 64 (6) , 1934-1950
Abstract
The interplay between host antiviral immunity and immunopathology during hepatitis E virus (HEV) infection determines important clinical outcomes. We characterized the specificity, functionality, and durability of host T‐cell responses against the full‐length HEV virus and assessed a novel “Quantiferon” assay for the rapid diagnosis of HEV infection. Eighty‐nine volunteers were recruited from Oxford, Truro (UK), and Toulouse (France), including 44 immune‐competent patients with acute HEV infection, 18 HEV‐exposed immunosuppressed organ‐transplant recipients (8 with chronic HEV), and 27 healthy volunteers. A genotype 3a peptide library (616 overlapping peptides spanning open reading frames [ORFs] 1‐3) was used in interferon‐gamma (IFN‐γ) T‐cell ELISpot assays. CD4+/CD8+ T‐cell subsets and polyfunctionality were defined using ICCS and SPICE analysis. Quantification of IFN‐γ used whole‐blood stimulation with recombinant HEV‐capsid protein in the QuantiFERON kit. HEV‐specific T‐cell responses were detected in 41/44 immune‐competent HEV exposed volunteers (median magnitude: 397 spot‐forming units/106 peripheral blood mononuclear cells), most frequently targeting ORF2. High‐magnitude, polyfunctional CD4 and CD8+ T cells were detected during acute disease and maintained to 12 years, but these declined over time, with CD8+ responses becoming more monofunctional. Low‐level responses were detectable in immunosuppressed patients. Twenty‐three novel HEV CD4+ and CD8+ T‐cell targets were mapped predominantly to conserved genomic regions. QuantiFERON testing demonstrated an inverse correlation between IFN‐γ production and the time from clinical presentation, providing 100% specificity, and 71% sensitivity (area under the receiver operator characteristic curve of 0.86) for HEV exposure at 0.3 IU/mL. Conclusion: Robust HEV‐specific T‐cell responses generated during acute disease predominantly target ORF2, but decline in magnitude and polyfunctionality over time. Defining HEV T‐cell targets will be important for the investigation of HEV‐associated autoimmune disease. (Hepatology 2016;64:1934‐1950).Keywords
Funding Information
- Medical Research Council (MRC) UK
- NIHR Oxford Biomedical Research Centre
- Wellcome Trust
- MRC Case studentship
This publication has 64 references indexed in Scilit:
- Evolution of the hepatitis E virus hypervariable regionJournal of General Virology, 2012
- Cytokine Profiles, CTL Response and T Cell Frequencies in the Peripheral Blood of Acute Patients and Individuals Recovered from Hepatitis E InfectionPLOS ONE, 2012
- SSE: a nucleotide and amino acid sequence analysis platformBMC Research Notes, 2012
- Standardization of Hepatitis E Virus (HEV) Nucleic Acid Amplification Technique-Based Assays: an Initial Study To Evaluate a Panel of HEV Strains and Investigate Laboratory PerformanceJournal of Clinical Microbiology, 2011
- Peptide antagonism as a mechanism for NK cell activationProceedings of the National Academy of Sciences, 2010
- Hepatitis E Virus Genotype 3 Diversity, FranceEmerging Infectious Diseases, 2009
- Hepatitis E: an emerging infection in developed countriesThe Lancet Infectious Diseases, 2008
- Cellular Immune Responses in Acute Hepatitis E Virus Infection to The Viral Open Reading Frame 2 ProteinViral Immunology, 2007
- Seroprevalence of Hepatitis E Virus Infection, Rural Southern People’s Republic of ChinaEmerging Infectious Diseases, 2006
- T‐cell epitope mapping of ORF2 and ORF3 proteins of human hepatitis E virusJournal of Viral Hepatitis, 2006